Free Trial

Turnstone Biologics (TSBX) Competitors

Turnstone Biologics logo
$0.34 +0.00 (+1.40%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$0.34 +0.00 (+0.18%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TSBX vs. FGEN, ALLK, INKT, CALC, SCLX, RANI, GRCE, CVKD, ABVC, and DARE

Should you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include FibroGen (FGEN), Allakos (ALLK), MiNK Therapeutics (INKT), CalciMedica (CALC), Scilex (SCLX), Rani Therapeutics (RANI), Grace Therapeutics (GRCE), Cadrenal Therapeutics (CVKD), ABVC BioPharma (ABVC), and Daré Bioscience (DARE). These companies are all part of the "pharmaceutical products" industry.

Turnstone Biologics vs.

Turnstone Biologics (NASDAQ:TSBX) and FibroGen (NASDAQ:FGEN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and community ranking.

FibroGen received 343 more outperform votes than Turnstone Biologics when rated by MarketBeat users. Likewise, 58.81% of users gave FibroGen an outperform vote while only 44.44% of users gave Turnstone Biologics an outperform vote.

CompanyUnderperformOutperform
Turnstone BiologicsOutperform Votes
4
44.44%
Underperform Votes
5
55.56%
FibroGenOutperform Votes
347
58.81%
Underperform Votes
243
41.19%

52.5% of Turnstone Biologics shares are owned by institutional investors. Comparatively, 72.7% of FibroGen shares are owned by institutional investors. 32.1% of Turnstone Biologics shares are owned by company insiders. Comparatively, 3.1% of FibroGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Turnstone Biologics has a net margin of 0.00% compared to FibroGen's net margin of -67.66%. FibroGen's return on equity of 0.00% beat Turnstone Biologics' return on equity.

Company Net Margins Return on Equity Return on Assets
Turnstone BiologicsN/A -105.99% -87.27%
FibroGen -67.66%N/A -36.17%

Turnstone Biologics has higher revenue and earnings than FibroGen. FibroGen is trading at a lower price-to-earnings ratio than Turnstone Biologics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Turnstone Biologics$19.31M0.41-$55.20M-$2.73-0.12
FibroGen$7.00M4.74-$284.23M-$0.10-3.29

In the previous week, FibroGen had 6 more articles in the media than Turnstone Biologics. MarketBeat recorded 6 mentions for FibroGen and 0 mentions for Turnstone Biologics. Turnstone Biologics' average media sentiment score of 0.00 beat FibroGen's score of -0.90 indicating that Turnstone Biologics is being referred to more favorably in the media.

Company Overall Sentiment
Turnstone Biologics Neutral
FibroGen Negative

Turnstone Biologics has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Comparatively, FibroGen has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Turnstone Biologics currently has a consensus price target of $0.45, suggesting a potential upside of 32.59%. FibroGen has a consensus price target of $10.00, suggesting a potential upside of 2,944.14%. Given FibroGen's stronger consensus rating and higher possible upside, analysts plainly believe FibroGen is more favorable than Turnstone Biologics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Turnstone Biologics
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
FibroGen
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

FibroGen beats Turnstone Biologics on 11 of the 18 factors compared between the two stocks.

Get Turnstone Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TSBX vs. The Competition

MetricTurnstone BiologicsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$7.85M$2.93B$5.33B$8.39B
Dividend YieldN/A1.68%5.21%4.11%
P/E Ratio-0.1031.1826.7119.71
Price / Sales0.41398.78386.13120.55
Price / CashN/A168.6838.2534.62
Price / Book0.083.236.774.50
Net Income-$55.20M-$72.35M$3.23B$248.22M
7 Day Performance-2.33%5.01%1.80%0.56%
1 Month Performance9.66%5.63%11.10%13.17%
1 Year Performance-87.52%-27.04%17.11%7.30%

Turnstone Biologics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSBX
Turnstone Biologics
2.8461 of 5 stars
$0.34
+1.4%
$0.45
+32.6%
-87.5%$7.85M$19.31M-0.1082
FGEN
FibroGen
4.3663 of 5 stars
$0.30
-2.7%
$10.00
+3,264.7%
-73.3%$30.03M$29.62M-0.24570
ALLK
Allakos
4.2039 of 5 stars
$0.33
-0.3%
$2.00
+508.8%
N/A$29.69MN/A-0.16190
INKT
MiNK Therapeutics
2.5721 of 5 stars
$7.32
-3.7%
$37.50
+412.3%
-25.9%$29.03MN/A-1.8830
CALC
CalciMedica
2.003 of 5 stars
$2.02
+0.5%
$18.00
+791.1%
-68.8%$28.22MN/A-1.8730
SCLX
Scilex
1.5365 of 5 stars
$4.04
-1.5%
$455.00
+11,162.4%
-88.4%$28.09M$56.59M-4.8780
RANI
Rani Therapeutics
2.2543 of 5 stars
$0.48
-21.7%
$12.00
+2,400.0%
-87.6%$27.59M$1.03M-0.45110News Coverage
Analyst Revision
GRCE
Grace Therapeutics
1.8393 of 5 stars
$2.66
-2.2%
$12.00
+351.1%
N/A$26.97MN/A-2.29N/A
CVKD
Cadrenal Therapeutics
2.778 of 5 stars
$13.79
+3.1%
$32.00
+132.1%
N/A$26.75MN/A-2.064News Coverage
Analyst Revision
ABVC
ABVC BioPharma
0.201 of 5 stars
$1.55
+13.9%
N/A+13.1%$25.98M$508,384.00-1.8030Gap Up
DARE
Daré Bioscience
1.3863 of 5 stars
$2.91
+1.0%
$24.00
+724.7%
-39.6%$25.75M$9,784.00-4.9330

Related Companies and Tools


This page (NASDAQ:TSBX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners